In-Use Safety Evaluation to Determine the Dermal Irritation Potential and Consumer Perception of a Test Material
- Conditions
- sensitive skin
- Registration Number
- JPRN-UMIN000047965
- Lead Sponsor
- ion Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Not provided
a) Female subject (if applicable) is pregnant, nursing, planning a pregnancy, or not using adequate birth control; b) Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study; c) Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would preclude application of the test material and/or could influence the outcome of the study; d) Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study; e) Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs; f) Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind; g) Subject has insulin-dependent diabetes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dermal evaluation by a dermatologist before and 4 weeks after use of a test material.
- Secondary Outcome Measures
Name Time Method